Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17157662 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Conditions: Eosinophilic Gastroenteritis;   Eosinophilic Esophagitis
Intervention: Drug: sirolimus
2 Unknown  Mepolizumab As a Steroid-Sparing Treatment Option in the Churg Strauss Syndrome
Condition: Churg Strauss Syndrome
Intervention: Biological: Mepolizumab

Indicates status has not been verified in more than two years